CHI Logo
Conference Banner

Speakers


Alain Bernard, Ph.D., Vice-President, Global Process Development and Industrialisation, UCB-Group

Alistair Kippen, Ph.D., Associate Director, Analytical Biochemistry, MedImmune Ltd.

Andy Hooker, Ph.D., Senior Director, Analytical Research & Development, Pharmaceutical Sciences, UCB-Celltech

Annie Van Broekhoven, Ph.D., Vice President, Biologicals, Innogenetics Biologicals

Asenath Rasmussen, Ph.D., Associate Research Fellow, Global Biologics Analytical R&D, Pfizer Global R&D

Bill Prince, Ph.D., Senior Director, Analytical Chemistry, BioMarin Pharmaceutical, Inc.

Boro Dropulic, Ph.D., President & CEO, Lentigen Corporation

Boyan Zhang, Ph.D., Scientist and Group Leader, Protein Analytical Chemistry, Genentech, Inc.

Christiane Jaeger, Ph.D., Head, Process Biochemistry, Roche Glycart AG

Dagmar Meissner, Owner & Founder, BioProcess Solutions

Daryl Fernandes, D. Phil., Chief Executive Officer, Ludger Ltd.

David Clark, Ph.D., Global Head of Pharma Pilot Plants, Centocor / J&J

Dell Farnan, Ph.D., Group Leader, Protein Analytical Chemistry, Genentech, Inc.

Eduard Orvisky, Ph.D., Senior Scientist I, Analytical Sciences, Human Genome Sciences, Inc.

Erik T. Fouts, Ph.D., Senior Director, Process Sciences, BioMarin Pharmaceutical, Inc.

Hansjoerg Toll, Ph.D., Head, Characterization, Biopharmaceutical Operations, Sandoz GmbH

Heidi Zhang, Ph.D., Fellow, Head of Mass Spectrometry PSP-ARD, Novartis Biologics

Hongcheng Liu, Ph.D., Associate Research Fellow, Process Sciences, Abbott Bioresearch Center

Irina Kulinets, Vice President, Regulatory and Clinical Affairs, Anika Therapeutics, Inc.

Jaya Goyal, Ph.D., Associate Director, Pre-Clinical & Clinical Development, Biogen Idec, Inc.

Jens H. Vogel, Ph.D., Global CMC Development Team Leader, Head, Isolation & Purification Department, Global Biological Development, Bayer Healthcare

John Desjarlais, Ph.D., Vice President, Research, Xencor, Inc.

Josef Vlasak, Ph.D., Senior Research Biochemist, Merck & Co., Inc.

Julia Edwards, Manager, Pharma Technical Regulatory, Genentech, Inc.

Julio Baez, Ph.D., Senior Science Fellow, FibroGen, Inc.

Jun Ouyang, Ph.D., Scientist, Protein Analytical Chemistry, Genentech, Inc.

Kathleen M. Williams, Ph.D, J.D., Partner, Intellectual Property Law, Edwards, Angell, Palmer & Dodge LLP

Kim Wong, Ph.D., Director, Facilities & cGMP Support, Process Development, sanofi pasteur

Les Johnson, Operations and CMC Consultant, Operations and CMC, Salamandra LLC

Louis-Christian Clauss Ph.D., General Coordinator, Clinical & Regulatory, L.F.B

Marco Riedel, Ph.D., Director, Quality Assurance, ProBioGen AG

Margit Jeschke, Ph.D., Head, Analytical Research & Development, Novartis Biologics / Process Sciences & Production, Novartis Pharma AG

Marjorie A. Shapiro, Ph.D., Chief, Laboratory of Molecular and Developmental Immunology, Division of Monoclonal Antibodies, CDER/FDA

Michael Weiser, Ph.D., Project Manager, Technology Transfer, Octapharma Pharmazeutika

Michele K. Dougherty, Ph.D., Product Quality Reviewer, Division of Monoclonal Antibodies, OBP/OPS/CDER/FDA

Monica Brzezinski, Ph.D., Principal Scientist, Biotherapeutics, Analytical Research & Development, Pfizer, Inc.

Nicolas Mourier, Ph.D., Director, Product Development, CMC, Peptimmune, Inc.

Paul R. Mehelik, M.S., M.B.A., Principal Scientist & Group Leader, ARD, Pfizer Global Biologics

Peter Sondermann, Ph.D., Chief Scientific Officer, SuppreMol GmbH

Qin (Chin) Zou, Senior Principal Scientist, Bioprocess Analytic Department, Pfizer, Inc.

Reed J. Harris, Senior Director, Protein Analytical Chemistry, Genentech, Inc.

Ron Taticek, Associate Director, CMC Regulatory Affairs, Genentech, Inc.

Shelly A. Pizarro, Ph.D., Scientist, Process Research and Development, Genentech, Inc.

Steffen Gross, Ph.D., Monoclonal and Polyclonal Antibodies, Paul-Ehrlich Institute

Suketu Desai, Ph.D., Vice President, Chemistry, Manufacturing, Controls & Quality, Ception Therapeutics, Inc.

Susan Hurst, Ph.D., Associate Research Fellow, Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D

Tina S. Morris, Ph.D., Vice President, Biologics and Biotechnology, United States Pharmacopeial Convention

Wassim Nashabeh, Ph.D, Senior Director, CMC Regulatory Policy & Strategy, Genentech, Inc.

William F. Bennett, Ph.D., Principal, Bioscope Associates, formerly Senior Director, Science & Policy Assessment and Head, Bioprocess Development, Genentech, Inc.

Xu-Rong Jiang, Ph.D., Associate Director, Analytical Biochemistry, MedImmune LLC

Zhuchun Wu, Ph.D., Senior Scientist, Analytical Sciences, Human Genome Sciences, Inc.

By Series:
By Region: